Skip to main content
SpringerLink
Log in

Choosing Hormone Replacement Therapy

  • Chapter
Reducing Breast Cancer Risk in Women

Part of the book series: Developments in Oncology ((DION,volume 75))

  • 51 Accesses

Abstract

The menopause may have serious health consequences but maintaining the semblance of the premenopausal state by means of hormone replacement therapy also involves problems. The decision to use hormone replacement therapy is not simple and the best agent or agents to be used are not defined. The studies which have examined risks and benefits have not made clear which is greater-risk or benefit. Clinical application of such therapy involves careful assessment in each individual.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cann, C., Genant, H., Ettinger, B., Gordon, G. (1980). Spinal mineral bone loss in oophorectomized women. J. Am. Med. Assoc., 244, 2056–2059.

    Article  CAS  Google Scholar 

  2. Mazess, R. (1982). On aging bone loss. Clin. Orthop., 165, 239–252.

    PubMed  Google Scholar 

  3. Riggs, B., Melton, L. (1986). Involutional osteoporosis. N. Engl. J. Med., 314, 1676–1685.

    Article  PubMed  CAS  Google Scholar 

  4. Riggs, B., Melton, L. (1992). The prevention and treatment of osteoporosis. N. Engl. J. Med. 327, 620–627.

    Article  PubMed  CAS  Google Scholar 

  5. Proceedings of the National Conference on Women’s Health Series (1987). Special Topic conference on Osteoporosis. J.U.S. Public Health Service, 48, (Suppl.), 50–51.

    Google Scholar 

  6. Consensus Development Conference (1991). Prophylaxis and treatment of osteoporosis. Am. J. Med., 90, 107–110.

    Article  Google Scholar 

  7. Gordon, T., Kannel, W.B., Hjortland, M.C. et al. (1978). Menopause and coronary heart disease. Ann. Intern. Med., 85, 157–161.

    Google Scholar 

  8. Rosenberg, L., Hennekens, C.H.E., Rosner, B. et al. (1981). Early menopause and the risk of myocardial infarction. Am. J. Obstet. Gynecol., 139, 47–51.

    PubMed  CAS  Google Scholar 

  9. Thomas, D.B. (1988). Steroid hormones and medications that alter cancer risks. Cancer, 62, 1755–1767.

    Article  PubMed  CAS  Google Scholar 

  10. Persson, I., Adami, H., Bergkvist, L. et al. (1989). Risk of endometrial cancer after treatment with estrogens alone or in conjunction with progestogens: Results of a prospective study. Br. Med. J., 298, 147–151.

    Article  CAS  Google Scholar 

  11. Antunes, C.M.F., Stolley, P.D., Rosenshein, N.B. et al. (1979). Endometrial cancer and estrogen use. Report of a large case-control study. N. Engl. J. Med., 300, 9–13.

    Article  PubMed  CAS  Google Scholar 

  12. A Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center (1974). Surgically confirmed gallbladder disease, venous thromboembolism and breast tumors in relation to postmenopausal estrogen therapy. N. Engl. J. Med., 290, 9–15.

    Google Scholar 

  13. Petitti, D.B., Sydney, S., Perlman, J.A. (1988). Increased risk of cholecystectomy in users of supplemental estrogen. Gastroenterology, 94, 91–95.

    PubMed  CAS  Google Scholar 

  14. Van Erpecum, K.J., Van Berge-Henegouwen, G.P., Verschoor, L., Stoelwinder, B., Willikens, F.L. (1991). Different hepatobiliary effect of oral and transdermal estradiol in postmenopausal women. Gastroenterology, 100, 482–488.

    PubMed  Google Scholar 

  15. Dupont, W.B., Page, D.L. (1987). Breast cancer risk associated with proliferative disease, age at first birth and family history of breast cancer. Am. J. Epidemiol, 125, 769–779.

    PubMed  CAS  Google Scholar 

  16. Henderson, I.C. (1993). Risk factors for breast cancer development. Cancer, 71, 2127–2140.

    Article  PubMed  CAS  Google Scholar 

  17. Colditz, G.A., Willett, W.C., Hunter, D.J. et al. (1993). Family history, age and risk of breast cancer. Prospective data from the nurse’s health study. J. Am. Med. Assoc., 270, 338–343.

    Article  CAS  Google Scholar 

  18. Kelsey, K.J., Gammon, M.D. (1990). Epidemiology of breast cancer. Epidemiol. Rev., 12, 228–240.

    PubMed  CAS  Google Scholar 

  19. Sellers, T.A., Kushi, L.H., Potter, J.D. et al. (1992). Effect of family history, body-fat distribution and reproductive factors on the risk of postmenopausal breast cancer. N. Engl. J. Med., 326, 1323–1329.

    Article  PubMed  CAS  Google Scholar 

  20. Nab, H.W., Googd, A.C., Coommelin, M.A. et al. (1993). Breast cancer incidence in the Southeastern Netherlands, 1960–1989: Trends in incidence and mortality. Eur. J. Cancer, 29A, 1557–1559.

    Article  PubMed  CAS  Google Scholar 

  21. Calle, E.E., Martin, L.M., Thun, M.J., Miracle, H.L., Heath, C.W. (1993). Family history, age, and risk of fatal breast cancer. Am. J. Epidemiol., 138, 675–681.

    PubMed  CAS  Google Scholar 

  22. Radimer, K., Siskind, V., Bain, C., Schofield, F. (1993). Relation between anthropometric indicators and risk of breast cancer among Australian women. Am. J. Epidemiol., 138, 77–89.

    PubMed  CAS  Google Scholar 

  23. Dupont, W.D., Page, D.L. (1991). Menopausal estrogen replacement therapy and breast cancer. Arch. Int. Med., 151, 67–72.

    Article  CAS  Google Scholar 

  24. Armstrong, B.K. (1988). Oestrogen therapy after the menopause -boon or bane? Med. J. Austral., 148, 213–214.

    PubMed  CAS  Google Scholar 

  25. Steinberg, K.K., Thacker, S .B., Smith, S.J. et al. (1991). A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. J. Am. Med. Assoc., 265, 1985–1990.

    Article  CAS  Google Scholar 

  26. Silero-Arenas, M., Delgado-Rodriquez, M., Rodiques-Canteras, R., Bueno-Cavanillas, A., Galvey-Vargas, R. (1992). Menopausal hormone-replacement therapy and breast cancer: a meta-analysis. Obstet. Gynecoi., 79, 286–294.

    Google Scholar 

  27. Grady, D., Rubin, S.M., Petitte, D.B. et al. (1992). Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann. Intern. Med., 117, 1016–1037.

    PubMed  CAS  Google Scholar 

  28. Colditz, G.A., Egan, K.M., Stampfer, M.J. (1993). Hormone replacement therapy and risk of breast cancer: Results from epidemiologic studies. Am. J. Obstet. Gynecol., 168, 1473–1480.

    PubMed  CAS  Google Scholar 

  29. Byrd, B.F., Burch, J.C., Vaughn, W.K. (1927). The impact of long-term estrogen support after hysterectomy: a report of 1016 cases. Ann. Surg., 185, 574–580.

    Article  Google Scholar 

  30. Hunt, K., Vessey, M., McPherson, K. (1990). Mortality in a cohort of long-term users of hormone-replacement therapy: our updated analysis. Br. J. Obstet. Gynecol., 97, 1080–1086.

    Article  CAS  Google Scholar 

  31. Bergkvist, L., Adami, H., Persson, I. et al. (1989). Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen-replacement therapy. Am. J. Epidemiol, 130, 221–228.

    PubMed  CAS  Google Scholar 

  32. Brinton, L.A., Hoover, R., Fraumeni, J.F. (1986). Menopausal oestrogens and breast cancer risk: an expanded case-control study. Br. J. Cancer, 54, 825–832.

    Article  PubMed  CAS  Google Scholar 

  33. Lufkin, E., Carpenter, P., Ory, S., Malkasion, G., Edmanson, J. (1988). Estrogen replacement therapy: current recommendations. Mayo Clin. Proc., 63, 453–456.

    Article  PubMed  CAS  Google Scholar 

  34. Stuerkel, C. (1989). Menopause and estrogen replacement therapy. Psychiatr. Clin. North. Am., 12, 133–152.

    Google Scholar 

  35. Hillmer, B., Hollenberg, J., Parker, S. (1986). Post-menopausal estrogens in prevention of osteoporosis benefit virtually without risk if cardiovascular effects are considered. Am. J. Med., 80,1115–1127.

    Article  Google Scholar 

  36. Harris, S., Genant, H., Baylink, D. et al. (1991). The effects of estrone (ogen) on spinal bone density of postmenopausal women. Arch. Intern. Med, 157, 1980–1984.

    Article  Google Scholar 

  37. Haarbo, J., Hassager, C., Jensen, S., Riis, B., Christianson, C. (1991). Serum lipids, liproproteins and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nor testosterone derivatives or 17-hydroxy progesterone derivatives. Ann. J. Med., 90, 584–589.

    CAS  Google Scholar 

  38. Hazzard, W. (1989). Estrogen replacement and cardiovascular disease: serum lipids and blood pressure effects. Am. J. Obstet. Gynecol., 161, 1847–1853.

    PubMed  CAS  Google Scholar 

  39. Barrett-Connor, E. (1992). Risks and benefits of replacement estrogen. Ann. Rev. Med., 43, 239–251.

    Article  PubMed  CAS  Google Scholar 

  40. McGill, H. (1989). Sex steroid hormone-receptors in the cardiovascular system. Post Grad. Med., 17, 64–68.

    Google Scholar 

  41. Williams, J.K., Adams, M.R., Kopfenstein, H.S. (1990). Estrogen modulates responses of atherosclerotic coronary arteries. Circulation, 81, 1680–1687.

    Article  PubMed  CAS  Google Scholar 

  42. Pines, A., Fishman, E.Z., Levo, Y. et al. (1991). The effects of hormone replacement therapy in normal postmenopausal women: measurements of Doppler-derived parameters of aortic flow. Am. J. Obstet. Gynecol., 164, 806–812.

    PubMed  CAS  Google Scholar 

  43. Henderson, B.E., Paganini-Hill, A., Ross, R.K. (1991). Decreased mortality in users of estrogen replacement therapy. Arch. Intern. Med., 151, 75–78.

    Article  PubMed  CAS  Google Scholar 

  44. Kennedy, D.L., Baum, C., Forbes, M.B. (1985). Non-contraceptive estrogens and progestins: use pattern over-time. Obstet. Gynecol., 65, 441–446.

    PubMed  CAS  Google Scholar 

  45. Hemminski, E., Kennedy, D.L., Baum, C. et al. (1988). Prescribing of noncontraceptiveestrogen and progestins in the United States, 1974–86. Am. J. Public. Health 78, 1478–1481.

    Article  Google Scholar 

  46. Reginster, J.Y., Christiansen, C., Dequinze, B. et al. (1993). Effect of transdermal 17 betaestradiol and oral conjugated equine estrogens on biochemical parameters of bone resorption in natural menopause. Calcif.-Tissue-Int., 53, 13–16.

    Article  PubMed  CAS  Google Scholar 

  47. Lindsay, R. (1993). Hormone replacement therapy for prevention and treatment of osteoporosis. Am. J. Med., 95, 375–395.

    Article  Google Scholar 

  48. Ferguson, K.J., Hoegh, C., Johnson, S. (1989). Estrogen replacement therapy: survey of women’s knowledge and attitudes. Arch. Intern. Med., 149, 133–136.

    Article  PubMed  CAS  Google Scholar 

  49. Schmitt, N., Gogate, J., Rothert, M. et al. (1991) Capturing and clustering women’s judgement policies. The case of hormonal therapy for menopause. J. Geronto., 46, 92–101.

    Article  Google Scholar 

  50. Kadri, A.Z. (1991). Hormone replacement therapy -a survey of perimenopausal women in a community setting. Brit. J. General Practice, 41, 109–112.

    CAS  Google Scholar 

  51. Vassilopoulou-Sellin, R., Zolinski, C. (1992). Estrogen replacement therapy in women with breast cancer: A survey of patient attitudes. Am. J. Med. Sci., 304, 145–149.

    Article  PubMed  CAS  Google Scholar 

  52. Groeneveld, F.P.M.J., Boreman, F.P., Barentsen, R. et al. (1993). Relationships between attitude toward menopause, well-being, and medical attention among women aged 45–60 years. Maturitas, 17, 77–88.

    Article  PubMed  CAS  Google Scholar 

  53. Hemmonki, E., Topo, P., Malin, M., Kangas, J. (1993). Physicians views on hormonal therapy around and after menopause. Maturitas, 16, 163–173.

    Article  Google Scholar 

  54. Welbush, J. (1993). The climacteric kaleidoscope: Questions and speculation. Maturitas, 16, 157–162.

    Article  Google Scholar 

  55. Nactigall, L.E. (1990). Enhancing patient compliance with hormone replacement therapy at menopause. Obstet. Gynecol., 75, 775–835.

    Google Scholar 

  56. Derby, C.A., Hume, A.L., McFarland, et al. (1993). Correlates of postmenopausal estrogen use and trends through the 1980’s in two Southeastern New England Communities. Am. J. Epidemiol. 137, 1125–1135.

    PubMed  CAS  Google Scholar 

  57. MacLennan, A.H., MacLennan, A., Wilson, D. (1993). The prevalence of oestrogen replacement therapy in South Australia. Maturitas, 16, 175–183.

    Article  PubMed  CAS  Google Scholar 

  58. Creasman, W.T. (1991). Estrogen replacement therapy: is previously treated cancer a contraindication? Obstet. Gynecol., 77, 309–312.

    Google Scholar 

  59. Theriault, R.L., Vassilopoulou-Sellin, R. (1991). A clinical dilemma: estrogen replacement therapy in postmenopausal women with a background of primary breast cancer. Ann. Oncol., 2, 709–717.

    PubMed  CAS  Google Scholar 

  60. Hutchinson-Williams, K., Gutmann, L. (1991). Estrogen replacement therapy (ERT) in high-risk cancer patients. Yale. J. Biol. Med., 64, 607–626.

    PubMed  CAS  Google Scholar 

  61. Marchant, D.J. (1993). Estrogen-replacement therapy after breast cancer. Risk versus benefits. Cancer, 71, 2169–2176.

    Article  PubMed  CAS  Google Scholar 

  62. Powles, T.J., Hukish, T., Casey, S., O’Brien M. (1993). Hormone replacement therapy after breast cancer. Lancet, 342, 60–61.

    Article  PubMed  CAS  Google Scholar 

  63. Stoll, B.A. (1989). Hormone replacement therapy in women treated for breast cancer. Eur. J. Cancer Clin. Oncol., 25, 1909–1913.

    Article  PubMed  CAS  Google Scholar 

  64. Wile, A.G., Opfell, R.W., Morgileth, D.A. (1993). Hormone replacement therapy in previously treated breast cancer patients. Am. J. Surg., 165, 372–375.

    Article  PubMed  CAS  Google Scholar 

  65. Disaia, P.J., Odicino, F., Grosen, E.A. et al. (1993). Hormone replacement therapy in breast cancer. Lancet, 342, 1232, (letter).

    Article  PubMed  CAS  Google Scholar 

  66. Theriault, R.L., Vassilopoulou-Sellin, R. (1994). Estrogen replacement therapy in younger women with breast cancer. J. Natl. Cancer Inst., (In press).

    Google Scholar 

  67. Vassilopoulou-Sellin, R., Theriault, R. (1994). A randomized prospective trial of estrogen replacement therapy in women with a history of breast cancer. J. Natl. Cancer Inst., (In press).

    Google Scholar 

  68. Lufkin, E.G., Org, S.J. (1994). Relative value of transdermal and oral estrogen therapy invarious clinical situations. Mayo Clin. Proc., 69,131–135.

    Article  PubMed  CAS  Google Scholar 

  69. Guidelines for counselling postmenopausal women about preventive hormone therapy. (1992). American College of Physicians. Ann. Int. Med., 117, 1038–1041.

    Google Scholar 

  70. Sporrong, T., Hellgren, M., Samsioe, G., Mattsson, L.-A. (1989). Metabolic effects of continuous estradiol-progestin therapy in postmenopausal women. Obstet. Cynecol., 73, 754–758.

    CAS  Google Scholar 

  71. MacLennan, A.H., MacLennan, A., Wenzel, S., Chambers, H.M., Eckert, K. (1993). Continuous low-dose oestrogen and progestogen hormone replacement therapy: a randomised trial. Med. J. Aust., 159, 102–106.

    PubMed  CAS  Google Scholar 

  72. Casper, R.F., Chapdelaine, A. (1993). Estrogen and interrupted progestin: A new concept for menopausal hormone replacement therapy. Am. J. Obstet. Gynecol., 168, 1188–1196.

    PubMed  CAS  Google Scholar 

  73. Christiansen, C., Riis, B.J. (1990). Five years with continuous combined oestrogen/progestogen therapy. Effects on calcium metabolism, lipoproteins, and bleeding pattern. Brit. J. Obstet. Gynaecol., 97, 1087–1092.

    Article  CAS  Google Scholar 

  74. Stevenson, J.C., Cust, M.P., Gangar, K.F. et al. (1990). Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women. Lancet, 335, 265–269.

    Article  Google Scholar 

  75. Whitehead, M.I., Fraser, D., Schenkel, L., Crook, D., Stevenson, J.C. (1990). Transdermal administration of oestrogen/progestagen hormone replacement therapy. Lancet, 335, 310–312.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Richard L. Theriault
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura L. Boehnke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rena V. Sellin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Oncology Department, St. Thomas’ Hospital, London, UK

    Basil A. Stoll (Honorary Consulting Physician, Consultant) (Honorary Consulting Physician, Consultant)

  2. Joint Breast Clinic, Royal Free Hospital, London, UK

    Basil A. Stoll (Honorary Consulting Physician, Consultant) (Honorary Consulting Physician, Consultant)

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Theriault, R.L., Boehnke, L.L., Sellin, R.V. (1995). Choosing Hormone Replacement Therapy. In: Stoll, B.A. (eds) Reducing Breast Cancer Risk in Women. Developments in Oncology, vol 75. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-0489-0_18

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-0489-0_18

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-4219-2

  • Online ISBN: 978-94-011-0489-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation